Gluz, O., Nitz, U., Liedtke, C., Christgen, M., Grischke, E., Forstbauer, H., Braun, M., Warm, M., Hackmann, J., Uleer, C., Aktas, B., Schumacher, C., Lindner, C., Kümmel, S., Kates, R. E., Potenberg, J., Staib, P., Wuerstlein, R., Kreipe, H. H., & Harbeck, N. (n.d.). lBA13Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095504052.0x000030